• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质量指标与医疗保险政策的交叉点。

Intersection of quality metrics and Medicare policy.

机构信息

Research & Performance Measurement, Pharmacy Quality Alliance, Fairfax Station, VA, USA.

出版信息

Ann Pharmacother. 2011 Dec;45(12):1582-4. doi: 10.1345/aph.1Q562. Epub 2011 Nov 1.

DOI:10.1345/aph.1Q562
PMID:22045907
Abstract

The federal government is increasing its push for a high-value health care system by increasing transparency and accountability related to quality. The Medicare program has begun to publicly rate the quality of Medicare plans, including prescription drug plans, and is transforming its payment policies to reward plans that deliver the highest levels of quality. These policies will have a cascade effect on pharmacies and pharmacists as the Medicare plans look for assistance in improving the quality of medication use. This commentary describes the Medicare policies directed toward improvement of quality and their effect on pharmacy payment and opportunities for pharmacists to affirm their role in a high-quality medication use system.

摘要

联邦政府正在通过提高与质量相关的透明度和问责制来推动高价值的医疗保健系统。医疗保险计划已开始公开评定医疗保险计划(包括处方药计划)的质量,并正在转变其支付政策,以奖励提供最高质量水平的计划。随着医疗保险计划寻求帮助提高用药质量,这些政策将对药店和药剂师产生级联效应。本文述评描述了旨在提高质量的医疗保险政策及其对药店支付的影响,以及药剂师在高质量用药系统中确认其角色的机会。

相似文献

1
Intersection of quality metrics and Medicare policy.质量指标与医疗保险政策的交叉点。
Ann Pharmacother. 2011 Dec;45(12):1582-4. doi: 10.1345/aph.1Q562. Epub 2011 Nov 1.
2
Physician payment 2008 for interventionalists: current state of health care policy.2008年介入治疗医生的薪酬:医疗保健政策现状
Pain Physician. 2007 Sep;10(5):607-26.
3
The policy on paying for treating hospital-acquired conditions: CMS officials respond.支付医院获得性疾病治疗费用的政策:CMS 官员做出回应。
Health Aff (Millwood). 2009 Sep-Oct;28(5):1494-7. doi: 10.1377/hlthaff.28.5.1494.
4
Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.医疗保险星级评定:关于社区药房与管理式医疗合作关系质量的利益相关方程序。
J Am Pharm Assoc (2003). 2014 May-Jun;54(3):228-40. doi: 10.1331/JAPhA.2014.13180.
5
Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.与独立药房所有者对医疗保险处方药部分合同满意度相关的因素。
Res Social Adm Pharm. 2010 Jun;6(2):121-9. doi: 10.1016/j.sapharm.2010.03.004. Epub 2010 May 7.
6
Commentary. The imperatives for change in the US health care payment and delivery systems are clear.
Adv Chronic Kidney Dis. 2008 Jan;15(1):7-9. doi: 10.1053/j.ackd.2007.10.013.
7
Changes in the Medicare home health care market: the impact of reimbursement policy.医疗保险家庭医疗保健市场的变化:报销政策的影响。
Med Care. 2009 Mar;47(3):302-9. doi: 10.1097/MLR.0b013e31818afbf9.
8
Driving population health through accountable care organizations.通过责任医疗组织推动人口健康。
Health Aff (Millwood). 2011 Jan;30(1):41-50. doi: 10.1377/hlthaff.2010.0935.
9
Introduction: Medicare quality improvement organizations--activities and partnerships.引言:医疗保险质量改进组织——活动与合作关系
J Manag Care Pharm. 2007 Jul;13(6 Suppl B):S3-6.
10
Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.医疗保险计划;医疗保险处方药折扣卡。有意见征求期的暂行最终规则。
Fed Regist. 2003 Dec 15;68(240):69839-927.